Form 8-K - Current report:
SEC Accession No. 0001558370-24-000546
Filing Date
2024-01-25
Accepted
2024-01-25 16:31:28
Documents
15
Period of Report
2024-01-25
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ampe-20240125x8k.htm   iXBRL 8-K 36027
2 EX-5.1 ampe-20240125xex5d1.htm EX-5.1 18984
3 GRAPHIC ampe-20240125xex5d1001.jpg GRAPHIC 6611
  Complete submission text file 0001558370-24-000546.txt   210904

Data Files

Seq Description Document Type Size
4 EX-101.SCH ampe-20240125.xsd EX-101.SCH 3645
5 EX-101.LAB ampe-20240125_lab.xml EX-101.LAB 19420
6 EX-101.PRE ampe-20240125_pre.xml EX-101.PRE 13534
9 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20240125x8k_htm.xml XML 4858
Mailing Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112
Business Address 9800 MOUNT PYRAMID COURT, SUITE 400 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

EIN.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35182 | Film No.: 24562619
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)